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Abstract
Background: Polymorphisms in the endotoxin-mediated TLR4 pathway genes have been associated with asthma
and atopy. We aimed to examine how genetic polymorphisms in innate immunity pathways interact with
endotoxin to influence asthma risk in children.
Methods: In a previous analysis of 372 children from the Boston Home Allergens and the Connecticut Childhood
Asthma studies, 7 SNPs in 6 genes (CARD15, TGFB1, LY96, ACAA1, DEFB1 and IFNG) involved in innate immune
pathways were associated with asthma, and 5 SNPs in 3 genes (CD80, STAT4, IRAK2) were associated with eczema.
We tested these SNPs for interaction with early life endotoxin exposure (n = 291), in models for asthma and
eczema by age 6.
Results: We found a significant interaction between endotoxin and a SNP (rs156265) in ACAA1 (p = 0.0013 for
interaction). Increased endotoxin exposure (by quartile) showed protective effects for asthma in individuals with at
least one copy of the minor allele (OR = 0.39 per quartile increase in endotoxin, 95% CI 0.15 to 1.01). Endotoxin
exposure did not reduce the risk of asthma in children homozygous for the major allele.
Conclusion: Our findings suggest that protective effects of endotoxin exposure on asthma may vary depending
upon the presence or absence of a polymorphism in ACAA1.
Background
Exposure to endotoxin, a component of the gram nega-
tive bacterial cell wall, has been associated with a lower
prevalence of asthma symptoms, and a decreased risk of
allergic sensitization in childhood [1-3]. Children
exposed to the farming environment, where microbial
exposures are high, have lower rates of asthma and
allergies [4,5]. The ability of endotoxin to modulate
innate immune response may explain its protective
effects. Endotoxin binds to the TLR4 receptor on anti-
gen presenting cells, initiating, through an MYD88
dependent pathway, the production of IL-12. Secretion
of IL-12 promotes the differentiation of naïve T cells
into Th1 cells that blunt the Th2 response implicated in
asthma and allergic disease [6]. T-regulatory cell func-
tion is enhanced in the presence of endotoxin, suggest-
ing an alternative protective mechanism for this gram-
negative bacterial component [6,7]. The effects of envir-
onmental endotoxin on allergic disease most likely
depend upon timing, dose and duration of exposure [8].
Genetics also play an important role in determining an
individual’s response to endotoxin. In fact, dose-
response curves for endotoxin and allergic disease risk
have been shown to vary markedly depending upon the
presence or absence of polymorphisms in innate
immune genes [9].
Thus far, gene by environment interaction studies
examining the impact of genetic polymorphisms on the
effects of endotoxin exposure have focused mainly on
SNPs in individual candidate genes, including CD14,
TLR4, and TLR2. For instance, endotoxin’sp r o t e c t i v e
effects are modified by the presence of SNPs in CD14, a
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[10-12]. For individuals with a polymorphism in TLR4
(+4434), high endotoxin exposure confers protective
effects against atopy [13]. In controlled exposure studies,
missense polymorphisms in TLR4 (Asp299Gly or
Thr399Ile) are associated with differences in airway
responsiveness to endotoxin [14]. Genetic polymorph-
i s m si nT L R 2m a yd e c r e a s et h er i s ko fa s t h m aa n d
atopy in children exposed to farming environments,
where microbial exposures are high [13].
While the majority of gene by environment interaction
analyses have focused on polymorphisms in these single
genes of interest, we considered multiple candidate
genes in the endotoxin-TLR binding pathway. Poly-
morphisms associated with asthma and eczema in our
cohort have been reported previously [15], and are
tested here for interaction with early-life endotoxin
exposure.
Methods
Study populations
Boston Home Allergens and Asthma Study
Subjects were recruited as part of a metropolitan Bos-
ton prospective birth cohort study to investigate the
relationships between indoor allergen exposure and the
development of asthma and other allergic diseases.
Details of the study design have been previously
described [16,17]. Between September 1994 and June
1996, 505 infants from 499 families were recruited
after delivery at the Brigham and Women’s Hospital in
Boston, Massachusetts. Inclusion criteria for the study
were maternal age ≥ 18 years, residence considered
safe without intention to move in the next 12 months,
maternal ability to speak English or Spanish, residence
within Route 128 (within the metropolitan area), and
parental report of a doctor’s diagnosis of asthma, hay
fever, or allergy to inhaled allergens. Children who
were born prematurely (< 36 weeks), had a major con-
genital anomaly, or were hospitalized in the neonatal
intensive care unit after delivery were excluded from
the study. Approval for this analysis was obtained from
the Institutional Review Board (IRB) of the Brigham
and Women’s Hospital. Informed consent was obtained
from the child’s primary caretaker at the time of the
first home visit. For subjects recruited into the Boston
Home Allergens and Asthma Study, blood samples
were collected at age 2-3 years, and again at 4-5 years
of age. Questionnaires investigating the subject’sh o m e
environmental characteristics (i.e. home dampness,
smoking, and rugs/carpets) and other relevant expo-
sures (i.e. daycare attendance, other siblings in the
home, and presence of pets) were obtained at the first
h o m ev i s i ta ta g e2 - 3m o n t h sa n dt h e na n n u a l l y
thereafter.
Connecticut Childhood Asthma Study
Between September 1996 and December 1998, 1002
families were recruited to participate in the Connecticut
Childhood Asthma Study. High risk families were
recruited after having had a child at one of five Connecti-
cut hospitals or a hospital in south central Massachusetts.
To be eligible, a family had to have a newborn infant
(index child) with a sibling less than 11 years old with phy-
sician diagnosed asthma. Study design and primary out-
comes of the study have been previously published [18,19].
Questionnaires on home characteristics and other relevant
exposures were administered at first home visit, quarterly
for the first three years, and then annually thereafter.
Approval was obtained from the IRB of each participating
institution and informed consent was obtained from the
mother of the study participant prior to entry.
Early Life Endotoxin Exposure
Early life exposure to lipopolysaccharide (LPS) from gram
negative bacteria was assessed in both cohorts at age 2-3
mths. We collected dust samples from infant’s homes by
vacuuming both the family room floor and an upholstered
chair most often used by the parent while holding the
infant. For the Boston Cohort, the biological activity of LPS
(endotoxin) was measured in house dust samples using the
kinetic Limulus Amoebocyte Lysate (LAL) assay. In the
Connecticut Cohort, 3-hydroxy fatty acids (3- OHFAs),
biomarkers of LPS that correlate with endotoxin, were
measured by GC/MS. Details of the kinetic Limulus Amoe-
bocyte Lysate and the GC/MS method for 3-OHFAs are
described elsewhere [20,21]. In the Connecticut Cohort, a
small sub-study was conducted to compare endotoxin
levels by LAL with levels of 3-OHFAs by GC/MS. Levels of
the 3-OHFA C14:0 showed the highest correlation with
LAL endotoxin levels (r = 0.9). Exposure to lipopolysac-
charide (endotoxin or C14:0 3-OHFA) was ranked by quar-
tile within each cohort. This four-level ranking variable
(with 1
st quartile as reference) was entered into statistical
models as an indicator of endotoxin exposure. There were
291 children with endotoxin exposure assessment, SNP
genotyping data, and health outcome data.
Measurement of total serum IgE
Serum samples from a subset of children from both
cohorts were analyzed for total IgE levels by using an
enzyme immunoassay based on the sandwich technique
(UNICAP system; Pharmacia Diagnostics, Kalamazoo,
Mich). A total of 272 children had available serum IgE
values for this analysis. All IgE values were converted to
the log-natural scale for analysis.
Genotyping and Identification of SNPs associated with
Asthma
Candidate genes were selected on the basis of their
involvement in the endotoxin and innate immune path-
ways. SNPs in 44 candidate genes were selected for
investigation if they were (1) tagging SNPs with r
2 <
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upstream and downstream of the first and last exons of
each gene, (2) non-synonymous SNPs resulting in an
amino acid change with minor allele frequency> 1%, or
(3) variants that had been previously associated with
either asthma or asthma-related phenotypes [15]. SNP
genotyping was performed using the Illumina BeadSta-
tion 500G (San Diego, CA, USA). If a significant interac-
tion was detected for SNPs flanking the exonic regions
of a candidate gene, then supplemental genotyping was
done to include more SNPs in the flanking region, as
well as additional SNPs in the candidate gene.
The Boston Home Allergens and Asthma and the Con-
necticut Childhood Asthma Study cohorts were similar
with respect to their geographic ascertainment area,
recruitment scheme, data collection time frames, and
data collection methods. In a similar manner to previous
w o r k ,t h et w oc o h o r t sw e r ec o m b i n e df o rt h i sa n a l y s i s
[15,17]. No evidence of population stratification was
detected in the combined cohort (p-value = 0.90). (A
total of 100 unlinked SNPs were genotyped in all subjects
and were analyzed according to the method proposed by
Pritchard and Rosenberg [22]). Population stratification
SNPs were chosen from the Celera dataset on the TSC
website http://snpdata.cshl.edu that were included in the
stratification panel, had a minor allele frequency ≥ 0.25
i nC a u c a s i a n s ,w e r eg r e a t e rt h a n1 0 0k ba p a r t ,a n dd i d
not map to a gene in SNPper http://snpper.chip.org/.
SNPs chosen had Illumina scores ≥ 0.65, indicating a
high likelihood of successful genotyping.
Linkage disequilibrium patterns were similar for the
two cohorts [17]. Due to inadequate sample size of
other ethnic groups, only Caucasian subjects were ana-
lyzed in this study. Asthma affection status was estab-
lished using parental report of a doctors’ diagnosis of
asthma. Children who had physician diagnosed asthma
during the first 6 years of life were defined as cases,
while the others were classified as non-asthma controls.
Furthermore, children who had a report of eczema dur-
ing the first 6 years of life were defined as cases and
those without were defined as non-eczema controls.
Association testing was performed using the case con-
trol based association testing (C2BAT) methodology.
Seven SNPs in 6 genes (ACAA1,TGF-b,D E F - b1, LY96,
CARD15, IFN-g) were associated with asthma (Addi-
tional file 1 Table S1), and 5 SNPs in 3 genes (CD80,
STAT4, IRAK2) were associated with eczema (Addi-
tional file 2 Table S2). We tested the interaction of
these SNPs with endotoxin exposure level in multiple
regression models, to determine if the effects of expo-
sure were modified by these genetic polymorphisms.
Statistical Analyses
To test for interactions between endotoxin exposure and
genetic polymorphisms in innate immune genes, we
entered the main effect of the SNP and endotoxin expo-
sure, along with a multiplicative interaction term (SNP
× endotoxin exposure) into models for the development
of the disease outcome (asthma or eczema) by age 6.
We used logistic regression for these analyses. For the
asthma outcome, seven multiple regression models were
constructed (one for each SNP associated with asthma
in the previous genetic association analysis), assuming a
dominant genetic model. (Although the previous genetic
association analysis assumed an additive genetic model,
we used a dominant genetic model to increase the
power to detect gene by environment interactions).
Models were adjusted for potential confounders, includ-
ing maternal asthma, day care (1-6 mths), low income,
breastfeeding, sex and cohort. We used Bonferroni cor-
rection (0.05/7 tests) to calculate a p-value threshold for
significance adjusted for multiple comparisons (p <
0.007). The same modeling procedure was conducted
for the eczema by age 6 outcome, using 5 a priori SNPs
(associated with eczema in a previous analysis), endo-
toxin exposure by quartile, and the multiplicative inter-
action term (SNP × endotoxin exposure). Potential
confounders, including maternal eczema, day care (1-6
mths), low income, breast feeding, sex and cohort were
controlled for in the eczema models.
Additionally, we examined total IgE (converted to nat-
ural log scale) at age 2 as an outcome variable. Samples
assayed for IgE with undetectable levels were assigned a
value of 0.175 kU/L (one half the limit of detection for
the assay). The main effects of endotoxin exposure and
genetic polymorphisms (SNPs previously associated with
asthma or eczema) were entered into multiple regres-
sion models for total IgE, along with an interaction term
(SNP × endotoxin quartile).
Results
Population Characteristics
The Boston Home Allergens and Asthma Cohort and
Connecticut Childhood Asthma Cohort were compar-
able in recruitment scheme, geographic ascertainment,
and demographic characteristics, as previously described.
Therefore, we were able to combine the two cohorts,
enhancing our power to detect gene by environment
interactions. Of the 291 children with available data on
endotoxin exposure, genotyping and health outcomes,
95 were identified as asthma cases, and 196 were con-
trols who did not have asthma. Asthmatic children were
m o r el i k e l yt ob eb o y s ,a n dw e r em o r el i k e l yt oh a v ea
maternal history of asthma or eczema. In all other
respects, asthmatic children were similar to controls
(Table 1). Approximately half of the asthma cases and
controls came from each cohort (48 asthma cases and
100 controls from the Connecticut cohort; 47 asthma
cases and 96 controls from the Boston cohort). In the
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controls; in the Boston cohort, 73 cases and 67 controls.
The percentage of eczema cases from the Connecticut
cohort was higher (55% of total eczema cases) than the
percentage of eczema cases (45%) from the Boston
cohort (p = 0.053 for Chi Square). Although a subset of
Caucasian subjects had genotyping, the characteristics of
this subset (sex, maternal/paternal history of asthma and
eczema, day care attendance, and pet ownership) were
similar to those for the total number of Caucasian sub-
jects enrolled in the Boston (Additional file 3 Table S3)
and Connecticut cohorts (Additional file 4 Table S4).
Endotoxin Exposure
Exposure to LPS, assessed by either C14:0 3-OHFA
(Connecticut Cohort) or by LAL endotoxin (Boston
Cohort), was right skewed. In the Boston cohort, the
median endotoxin level was 80 and the inter-quartile
range was 52 to 126 EU/mg dust. In the Connecticut
cohort, the median C14:0 3-OHFA level was 49 and the
inter-quartile range was 36 to 81 pmoles/mg dust. In
order for the exposure metrics to be comparable, endo-
toxin/C14:0 3-OHFA levels were ranked according to
quartile. Home characteristics associated with increased
microbial biomarker levels (pet ownership and damp-
ness) were also similar between the cohorts.
Gene by Environment Interactions
We tested the 7 SNPs previously identified as predictors
of increased asthma risk [15] in models including an
interaction term for endotoxin exposure and the SNP of
interest. Of the 7 SNPs tested in logistic regression
models, rs156265 (ACAA1) interacted with endotoxin
exposure to decrease asthma risk (Figure 1). The p value
for this interaction term was p = 0.003, which was sig-
nificant after adjusting for multiple comparisons, and
remained so even after adjusting for potential confoun-
ders (breastfeeding, daycare attendance, income, mater-
nal asthma, sex and cohort) (p = 0.0013) (Table 2). The
effect of cohort (Connecticut/Boston) was not significant
in models for asthma, and did not alter the observed
interaction between endotoxin exposure and rs156265
SNP.
We genotyped this SNP in ACAA1 because it is
within 10 kb of MYD88, one of our candidate innate
immunity genes. ACAA1 (Acetyl CoA-Acyl Transferase)
is an enzyme important for b-oxidation of fatty acids in
peroxisomes. To investigate ACAA1 and MYD88 poly-
morphisms further, we genotyped additional SNPs in
both genes, including an MYD88 SNP (rs7744) with the
highest R
2 value (93%) corresponding to rs156265, as
well as two unrelated SNPs in MYD88 (rs6853) and
ACAA1 (rs5875). These SNPs were chosen based on the
linkage disequilibrium plot for polymorphisms in the
two genes generated using the reference HapMap data-
base (Figure 2). Creation of an LD plot using the sup-
plemental SNPs genotyped in the Connecticut/Boston
cohorts showed that rs7744 and rs156265 were not as
strongly associated (R
2 = 84%) as they were in the Hap-
Map reference population (Figure 3). The effects of
endotoxin exposure were modified by rs7744 in MYD88
(Figure 4), although the p value for the interaction term
(p = 0.03) was not statistically significant after adjust-
ment for multiple comparisons. The other two SNPs in
MYD88 and ACAA1 did not modify the effects of endo-
toxin exposure (Table 3). The effect of endotoxin
Table 1 Baseline Characteristics of Asthma Cases and
Controls
Variable Asthma
Cases
Asthma
Controls
Subjects (with DNA and endotoxin
exposure)
95 196
Gender (male)* 59/95 (0.62) 101/196 (0.51)
Asthmatic mother* 39/95 (0.41) 44/196 (0.22)
Asthmatic father 8/95 (0.08) 15/196 (0.08)
Mother with eczema*
, 34/95(0.36) 43/196 (0.22)
Father with eczema 13/95 (0.14) 21/196 (0.11)
Attended day care for the first six
months of life
30/95 (0.32) 57/196 (0.29)
Income Level:
< 30,000 6/95 (0.06) 12/196 (0.06)
30,000 to 50000 12/95 (0.13) 25/196 (0.13)
> 50,000 75/95 (0.79) 155/196 (0.79)
Ever Breastfed 75/95 (0.79) 152/196 (0.78)
Eczema diagnosis before age 6* 67/95 (0.71) 95/196 (0.48)
*Covariate varies significantly between asthma cases and asthma controls (p <
0.05)
1  1
Figure 1 Interaction between Endotoxin Exposure and SNP
(rs156265) in ACAA1 (Asthma frequency by endotoxin quartile
and genotype shown with 95% confidence intervals).
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action. Models without the interaction term for
rs156265 and endotoxin quartile did not show the pro-
tective effect of endotoxin on asthma risk.
None of the 5 SNPs previously associated with
eczema, [15] significantly modified the effect of early life
endotoxin exposure on the development of eczema by
age 6. Although p values for the interaction terms did
not reach statistical significance (p < 0.01) after adjust-
ment for multiple comparisons, two SNPs in CD80
(rs7630595, rs1307124) and one in IRAK2 (rs263408)
Table 2 Early life endotoxin exposure and asthma by age 6: Effect modification by genetic polymorphisms in the
endotoxin/TLR signaling pathway† (P values for interaction term shown)*
Gene SNP † Genotype OR (95%CI) for quartile increase in
endotoxin
p-value for Interaction (SNP*Endotoxin
Quartile)
ACAA1 (near
MYD88)
rs156265 CC
CG/GG
1.21 (0.92 to 1.57)
0.39 (0.15 to 1.01)
0.0013
LY96 rs16938758 AA
AT/TT
1.00 (0.77 to 1.30)
1.16 (0.52 to 2.55)
0.59
DEFB1 rs5743404 TT
TC/CC
1.24 (0.83 to 1.85)
0.95 (0.39 to 2.30)
0.28
IFNG rs2069718 CC
CT/TT
1.02 (0.69 to 1.49)
1.02 (0.43 to 2.42)
0.98
CARD15 rs5743291 GG
GA/AA
1.09 (0.84 to 1.42)
0.96 (0.41 to 2.25)
0.67
TGFB1 rs12980942 GG
GA/AA
1.04 (0.79 to 1.38)
0.96 (0.44 to 2.09)
0.75
TGFB1 rs6957 AA
AG/GG
1.04 (0.78 to 1.39)
0.97 (0.45 to 2.09)
0.77
†SNPs tested for interaction were previously associated with asthma in this cohort *Models adjusted for maternal asthma, daycare (1-6 mths), income level,
breastfeeding, cohort and sex

Figure 2 Linkage Disequilibrium Plot with R
2 (HapMap,
Caucasians) for SNPs in MYD88 and ACAA1.

Figure 3 Linkage Disequilibrium Plot with R
2 for SNPs in
combined Connecticut Childhood Asthma and Boston Home
Allergens Cohorts (Caucasians only).
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0.02 to 0.03) for the interaction with endotoxin expo-
sure (Table 4). SNPs previously associated with asthma
or eczema did not modify the effect of early life endo-
toxin exposure on total IgE levels (Additional file 5
Table S5).
Discussion
The results of our study show modification of the asso-
ciation between endotoxin exposure and asthma by a
genetic polymorphism in ACAA1, demonstrating that
higher home endotoxin levels appear to confer protec-
tion against asthma only in those individuals with this
SNP (rs156265). This finding is unique, and offers a
potential explanation for some of the inconsistent effects
of endotoxin exposure observed across multiple epide-
miological studies. In other work, investigators have pre-
viously shown markedly different dose response curves
in response to endotoxin, depending upon the presence
or absence of a SNP in CD14 [9]. A cross sectional
study of farm children also found that a polymorphism
in TLR4 determined whether or not endotoxin was
associated with decreased prevalence of atopy in chil-
dren [13]. Taken together, these studies (and ours)
demonstrate the importance of characterizing the
underlying genetic susceptibility of individuals before
attempting to determine the impact of environmental
exposures on allergic disease.
The majority of investigators examining the impact of
genetics on responses to environmental microbial expo-
sures in childhood asthma have focused on polymorph-
isms in CD14, TLR4, and TLR2. Our candidate gene
approach allowed us to scan polymorphisms in and
around multiple innate immune genes involved in the
endotoxin-TLR signaling pathway. By testing a broader
range of polymorphisms in biologically relevant genes,
we were able to capture an interaction with a poly-
morphism in ACAA1 that would not have been
observed using the single gene approach (TLR2, TLR4,
or CD14) commonly employed in gene by environment
interaction studies.
While we were able to detect effect modification of
e n d o t o x i ne x p o s u r eb yt h i sp r e v i o u s l yu n s t u d i e d
ACAA1 polymorphism (rs156265) we did not observe
significant main effects [15] or interactions for the clas-
sically studied genes (CD14, TLR4, TLR2) related to
endotoxin/TLR signaling. One potential explanation for
this is that other polymorphisms, such as those in and
around the cell signaling molecule MYD88, may play a
more important role in endotoxin mediated responses
than CD14, TLR2 or TLR4. (Other studies have not
queried this many genes in the pathway, and therefore
may have overlooked the importance of these other sig-
naling molecules). It is also possible that effect modifica-
tion by genetic polymorphisms may vary depending
upon the endotoxin levels experienced by the cohort.
T h em a j o r i t yo fg e n eb ye n v i r o n m e n ts t u d i e so ne n d o -
t o x i ne x p o s u r ea n da l l e r g i cd i s e a s eh a v ef o c u s e do n
farm children, who are exposed to higher levels of endo-
toxin than in suburban cohorts like ours.
Although ACAA1 is not an innate immune gene
involved in endotoxin TLR signaling, we genotyped the
rs156265 SNP in this region because of its proximity to
MYD88. MYD88 is an adaptor molecule involved in
endotoxin-mediated TLR signaling in innate immune
cells. The MYD88 dependent signaling cascade ulti-
mately results in the production of IL-12, a cytokine
responsible for differentiation of Th1 cells that down-
regulate the asthma-promoting Th2 response [6].
The ACAA1 SNP that modified the association
between endotoxin and asthma risk is found less than
1  1
Figure 4 Interaction between Endotoxin Exposure and SNP
(rs7744) in MYD88 (Asthma frequency by endotoxin quartile
and genotype shown with 95% confidence intervals).
Table 3 Additional MYD88 and ACAA1 Polymorphisms: Interactions with Endotoxin Exposure and Asthma Risk*
Gene SNP Base change p-value for Interaction (SNP*Endotoxin Quartile)
ACAA1 (near MYD88) rs156265 C > G 0.0013
MYD88 rs7744 A > G 0.03
MYD88 rs6853 A > G 0.78
ACAA1 rs5875 T > A 0.74
*Models adjusted for maternal asthma, daycare (1-6 mths), income level, breastfeeding, cohort and sex
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MYD88 transcription. The potential regulatory effect of
ACAA1 on MYD88 will require further investigation. In
addition to possible regulatory effects, ACAA1 may act
as part of a gene cluster. Recently, GWAS analyses have
begun to identify gene clusters that may play an impor-
tant role in allergic disease. For example, genetic poly-
morphisms within a tumor necrosis factor gene cluster
on chromosome 6p (including the genes for TNF-a and
lymphotoxin a) have been shown to influence asthma
and asthma-related phenotypes [23]. ACAA1 could act
as part of a similar gene cluster, responsible for altering
innate immune function in response to endotoxin.
The rs156265 SNP was not in linkage disequilibrium
with any SNPs in the MYD88 gene, suggesting that this
polymorphism is an independent factor in modifying
response to endotoxin, and not simply a surrogate for a
polymorphism in MYD88. The clear dose response
observed for the protective effects of endotoxin expo-
sure in those individuals with the ACAA1 SNP strength-
ens the evidence that this genetic polymorphism alters
response to environmental endotoxin, either through
regulation of MYD88 or by an alternative mechanism.
While this study clearly demonstrated a gene by envir-
onment interaction for a SNP in ACAA1 and environ-
mental endotoxin exposure, there were some study
limitations. In order to increase our power to detect
gene by environment interactions, we tested only those
genetic polymorphisms significantly associated with
asthma or eczema (regardless of environmental endo-
toxin exposure) in our cohort. This approach allowed us
to minimize the problem of multiple comparisons; how-
ever, we may have missed interactions between endo-
toxin exposure and genetic polymorphisms that were
not significant as main effects in models for asthma or
eczema risk. Even after combining two separate cohorts,
the total number of children with complete genotype,
endotoxin and health outcome data was relatively small.
Although we were able to detect a significant gene by
environment interaction, sample size may have reduced
our power to detect additional interactions between
endotoxin and other genetic polymorphisms. The use of
high risk cohorts in this study may limit the generaliz-
ability of our results to populations that are not high
risk. Lastly, we did not have a replication population for
this study, which would have provided additional confir-
mation of our findings.
Conclusion
Our findings suggest that protective effects of endotoxin
exposure on asthma may vary depending upon the pre-
sence or absence of a polymorphism in ACAA1.
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